Erythropoietin and renal transplantation

Kidney International, Supplement

Volumn 55, Issue 69, 1999, Pages

  Muirhead, Norman ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Allosensitization; Anemia; End stage renal disease; Erythropoiesis; RHuEPO

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; IRON;

ANEMIA; BLOOD TRANSFUSION; ERYTHROPOIESIS; GRAFT FAILURE; HUMAN; IRON METABOLISM; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; BLOOD; CHRONIC KIDNEY FAILURE; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; POLYCYTHEMIA;

ANEMIA; ERYTHROPOIETIN, RECOMBINANT; GRAFT REJECTION; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POLYCYTHEMIA;

EID: 0032915303     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.055suppl.69086.x     Document Type: Review

References (57)

1. SUNDAL E, KAESER U: Correction of the anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European Multicentre Study of 150 haemodialysis dependent patients. Nephrol Dial Transplant 4:979-987, 1989
2. ESCHBACH JW, ABDULHADI MH, BROWNE JK, DELANO BG, DOWNING MR, EGRIE JC, EVANS RW, FRIEDMAN EA, GRABER SE, HALEY NR: Recombinant human erythropoietin in anemic patients with end stage renal disease: Results of a phase III multicenter trial. Ann Intern Med 111:992-1000, 1989
3. CANADIAN ERYTHROPOIETIN STUDY GROUP: Association between recombinant erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300:573-578, 1990
4. NISSENSON AR, KORBET K, FABER M, BURKART J, GENTILE D, HAMBURGER R, MATTERN W, SCHREIBER M, SWARTZ R, VAN STONE J, WATSON A, ZIMMERMAN S: Multicenter trial of erythropoietin in patients on peritoneal dialysis. J Am Soc Nephrol 5:1517-1529, 1995
5. THE US RECOMBINANT HUMAN ERYTHROPOIETIN STUDY PREDIALYSIS GROUP: Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 18:50-59, 1991
6. OPELZ G: HLA antigen sensitization: A problem in graft survival. Transplant Proc 21:39-41, 1989
7. CECKA JM, CHO L: Sensitization, in Clinical Transplantation, 1988, edited by TERASAKI P, Los Angeles, UCLA Tissue Typing Laboratory, 1988, pp 365-374
8. OPELZ G, GRAVER B, MICKEY MR, TERASAKI PI: Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 32:177-183, 1981
9. DEIERHOI MH, SHROYER TW, HUDSON SL, BARGER BO, BARBER WH, CURTIS JJ, JULIAN BA, DIETHELM AG: Sustained high panel reactive antibodies in highly sensitized patients: Significance of continued transfusions. Transplant Proc 21:771-772, 1989
10. KEOWN PA FOR THE CANADIAN ERYTHROPOIETIN STUDY GROUP: Recombinant human erythropoietin and renal transplantation. Semin Nephrol 10:52-58, 1990
11. GRIMM PC, SINAI-TRIEMAN L, SEKIYA NM, ROBERTSON LS, ROBINSON BJ, FINE RF, ETTENGER RB: Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity. Kidney Int 38:12-19, 1990
12. FRIEDLAENDER MM, AZEM O, RUBINGER D, BRAUTBAR C: Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients. Isr J Med Sci 32:730-736, 1996
13. MOURAD G, CHONG G, CRISTOL JP, LORHO R, RAMOUNAU-PIGOT A, SEIGNALET J: Post transfusional anti-HLA hyperimmunization: Importance of erythropoietin. Nephrology 14:91-94, 1993
14. ETTENGER RB, MARIK J, GRIMM P: The impact of recombinant human erythropoietin therapy on renal transplantation. Am J Kidney Dis 18(Suppl 1):57-61, 1991
15. IWAKI Y, CECKA JM, TERASAKI PI: The transfusion effect in cadaveric kidney transplants: Yes or no. Transplantation 49:56-59, 1990
16. SCHMIDT R, KUPIN W, DUMLER F, VENKAT KK, MOZES M: Influence of the pretransplant hematocrit level on early graft function in cadaveric renal transplantation. Transplantation 55:1034-1040, 1993
17. LINDE T, WAHLBERG J, WIKSTROM B, DANIELSON BG: Outcome of renal transplant in patients treated with erythropoietin. Clin Nephrol 37:260-263, 1992
18. VASQUEZ EM, POLLAK R: Effect of pretransplant erythropoietin therapy on renal allograft outcome. Transplantation 62:1026-1028, 1996
19. Annual Report 1997 (vol 1), Dialysis and Renal Transplantation, Canadian Organ Replacement Register, Canadian Institute for Health Information, Ottawa, Ontario, March, 1997
20. BROWN JH, LAPPIN TRJ, ELDER GE, TAYLOR TN, BRIDGES JM, MCGEOWN MG: The initiation of erythropoiesis following renal transplantation. Nephrol Dial Transplant 4:1076-1079, 1989
21. SUN CH, WARD HJ, PAUL WL, KOYLE MA, YANAGAWA N, LEE DBN: Serum erythropoietin levels after renal transplantation. N Engl J Med 321:151-157, 1989
22. GOCH J, BIRGEGARD G, WIKSTROM B, TUFVESON G, DANIELSON BG: Serum erythropoietin levels in the immediate kidney post transplant period. Nephron 60:30-34, 1992
23. NAMPOORY MRN, JOHNY KV, AL-HILALI N, SESHADRI MS, KANAGASABHAPATHY AS: Erythropoietin deficiency and relative resistance causes anaemia in post renal transplant recipients with normal renal function. Nephrol Dial Transplant 11:177-181, 1996
24. ERSLEV AJ, WILSON J, CARO J: Erythropoietin titers in anemic, non-uremic patients. J Lab Clin Med 109:429-433, 1987
25. BESARAB A, CARO J, JARRELL BE, FRANCOS G, ERSLEV AJ: Dynamics of erythropoiesis following renal transplantation. Kidney Int 32: 526-536, 1987
26. JEFFREY RF, KENDALL RG, PRABHU P, NORFOLK DR, WILL EJ, DAVISON AM: Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation. Clin Nephrol 44:241-247, 1995
27. DEPAOLO VITALI E, RICCI G, PERINI L, MALACARNE F, VEDORATO M, GUERRA G, DAPPORTO M, GILLI P: The determination of plasma transferrin receptor as good index of erythropoietic activity in renal anemia and after renal transplantation. Nephron 72:552-556, 1996
28. BESHARA S, BIRGEGARD G, GOCH J, WAHLBERG J, WIKSTROM B, DANIELSON BG: Assessment of erythropoiesis following renal transplantation. Eur J Haematol 58:167-173, 1997
29. MOULIN B, OLLIER J, GEORGE F, PURGUS R, ROUX F, SAMPOL J, OLMER M: Serum erythropoietin and reticulocyte maturity index after renal transplantation: A prospective longitudinal study. Nephron 69:259-266, 1995
30. VAN WYCK DB, STIVELMAN JC, RUIZ J, KIRILIN LF, KATZ MA, OGDEN DA: Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int 35:712-716, 1989
31. ANASTASSIADES EG, HOWARTH D, HOWARTH J, SHANKS D, WATERS HM, HYDE K, GEARY CG, YIN TA, GOKAL R: Monitoring of iron requirements in renal patients on erythropoietin. Nephrol Dial Transplant 8:846-853, 1993
32. KALANTAR-ZADEH K, HOFFKEN B, WUNSCH H, FINK H, KLEINER M, LUFT FC: Diagnosis of iron deficiency in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 26:292-299, 1995
33. PIAZZA V, VILLA G, GALLI F, SEGAGNI S, BOVIO G, POGGIO FF, PICARDI L, SALVADEO A: Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis. Nephron 61:54-57, 1992
34. MUIRHEAD N, BARGMAN J, BURGESS E, JINDAL KK, LEVIN A, NOLIN L, PARFREY P: Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis 26(Suppl 2):S1-S24, 1995
35. TERUEL JL, VILA LT, HERNANDEZ RM, QUEREDA C, MARCEN R, METESANZ R, ORTUNO J: Serum ferritin levels after renal transplantation: A prospective study. Nephron 51:462-465, 1989
36. MOORE LW, SMITH SO, WINSETT RP, ACCHIARDO SR, GABER AO: Factors affecting erythropoietin production and correction of anemia in kidney transplant recipients. Clin Transplant 8:358-364, 1994
37. MILES AM, MARKELL MS, DASKALAKIS P, SUMRANI NB, HONG J, SOMMER BG, FRIEDMAN EA: Anemia following renal transplantation: Erythropoietin response and iron deficiency. Clin Transplant 11:313-315, 1997
38. LEZAIC V, DJUKANOVIC L, PAVLOVIC-KENTERA V: Recombinant human erythropoietin treatment of anemia in renal transplant recipients. Renal Fail 17:705-714, 1995
39. YOSHIMURA N, OKA T, OHMORI Y, AIKAWA I: Effects of recombinant human erythropoietin on the anemia of renal transplant recipients with chronic rejection. Transplantation 48:527-529, 1989
40. JINDAL KK, HIRSCH DJ, BELITSKY P, WHALEN MA: Low-dose subcutaneous erythropoietin corrects the anaemia of renal transplant failure. Nephrol Dial Transplant 7:143-146, 1992
41. TRAINDL O, BARNAS FRANZ M, FALGER S, KLAUSER R, KOVARIK J, GRAF H: Recombinant human erythropoietin in renal transplant patients with renal anemia. Clin Transplant 8:45-48, 1994
42. MUIRHEAD N, CATTRAN DC, ZALTZMAN J, JINDAL KK, FIRST MR, BOUCHER A, KEOWN PA, MUNCH LC, WONG C: Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction. J Am Soc Nephrol 5:1216-1222, 1994
43. VAN LOO A, VANHOLDER R, BERNAERT P, DE ROOSE J, LAMIERE N: Recombinant human erythropoietin corrects anemia during the first weeks after renal transplantation: A randomized prospective study. Nephrol Dial Transplant 11:1815-1821, 1996
44. KESSLER M, HESTIN D, MAYEUX PM, RENOULT E: Factors predisposing to post-renal transplant erythrocytosis: A prospective matched-pair control study. Clin Nephrol 45:83-89, 1996
45. QUNIBI WJ, BARRI Y, DEVOL B, AL-FURAYH O, SHETH K, TAHER S: Factors predictive of post-transplant erythrocytosis. Kidney Int 40:1153-1159, 1991
46. SUMRANI NB, DASKALAKIS P, MILES AM, SARKAR S, MARKELL MS, HONG JH, FRIEDMAN EA, SOMMER BG: Erythrocytosis after renal transplantation: A prospective analysis. ASAIO J 39:51-55, 1993
47. WICKRE CG, NORMAN DJ, BENNISON A, BARRY JM, BENNETT WM: Post renal transplant erythrocytosis: A review of 53 patients. Kidney Int 23:731-737, 1983
48. PERAZELLA MA, BIA MJ: Posttransplant erythrocytosis: Case report and review of newer treatment modalities. J Am Soc Nephrol 3:1653-1659, 1993
49. BARENBROCK M, SPIEKER C, RAHN K-H, ZIDEK W: Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis. Clin Nephrol 40:241-243, 1993
50. OREN R, BEERI M, HUBERT A, KRAMER MR, MATZNER Y: Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease. Arch Intern Med 157:1474-1478, 1997
51. BAKRIS GL, SAUTER ER, HUSSEY JL, FISHER JW, GABER AO. WINSETT R: Effects of theophylline on erythropoietin production in normal subjects and inpatients with erythrocytosis after renal transplantation. N Engl J Med 323:86-90, 1990
52. ISLAM MS, BOURBIGOT B, CODET JP, SONEY B, FOURNIER G, CLEDES J: Captopril induced correction of post renal transplant erythrocytosis. Transplant Int 2:222-225, 1990
53. CONLON PY, FARREL J, DONOHOE J, CARMODY M, WALSCHE JJ: The beneficial effect of enalapril on erythrocytosis after renal transplantation. Transplantation 56:217-219, 1993
54. MACGREGOR MS, ROWE PA, WATSON MA, RODGER RS, JUNOR BJ, BRIGGS JD: Treatment of post renal transplant erythrocytosis: Long term safety and efficacy of angiotensin-converting enzyme inhibitors. Nephron 74:517-521, 1996
55. AZIZI M, ROUSSEAU A, EZAN E, GUYENE TT, MICHELET S, GROGNET JM, LENFANT M, CORVOL P, MENARD J: Acute angiotensinconverting enzyme inhibition increases the plasma level of the natural stem cell regulator N-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 97:839-844, 1996
56. KLAASSEN RJ, VAN GELDER T, RISCHEN-VOS J, DEINUM J, MANIN'T VELD AJ, WEIMAR W: Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant patients with posttransplant erythrocytosis. Transplantation 64:780-782, 1997
57. KREUZER KA, ROCKSTROH JK, JELKMANN W, THIESEN A, SPENGLER U, SAUERBRUCH T: Inadequate erythropoietin response to anaemia in HIV patients: Relationship to serum levels of tumour necrosis factor α. interleukin-6 and their soluble receptors. Br J Haematol 96:235-239, 1997